{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:55:27Z","timestamp":1790855727355,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Princeton Catalysis Initiative, Bristol Myers Squibb"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77034-w","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:05:22Z","timestamp":1788206722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ER\u03b1 Micromap (\u00b5Map) proximity labeling reveals fulvestrant mechanisms"],"prefix":"10.1038","volume":"17","author":[{"given":"Chun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain O.","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Danga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-128X","authenticated-orcid":false,"given":"Ciaran P.","family":"Seath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Amako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack L.","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3248","authenticated-orcid":false,"given":"Joel W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6447-0587","authenticated-orcid":false,"given":"David W. C.","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"77034_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook, D. et al. Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat. Rev. Drug Discov. 13, 419\u2013431 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77034_CR2","doi-asserted-by":"crossref","unstructured":"Mechanism matters. Nat. Med. 16, 347\u2013347 (2010).","DOI":"10.1038\/nm0410-347"},{"key":"77034_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/cts.12980","volume":"14","author":"S Yamaguchi","year":"2021","unstructured":"Yamaguchi, S., Kaneko, M. & Narukawa, M. Approval success rates of drug candidates based on target, action, modality, application, and their combinations. Clin. Transl. Sci. 14, 1113\u20131122 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"77034_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43094-020-00047-9","volume":"6","author":"GK Kiriiri","year":"2020","unstructured":"Kiriiri, G. K., Njogu, P. M. & Mwangi, A. N. Exploring different approaches to improve the success of drug discovery and development projects: a review. Future J. Pharm. Sci. 6, 27 (2020).","journal-title":"Future J. Pharm. Sci."},{"key":"77034_CR5","first-page":"179","volume":"34","author":"J Miner","year":"2007","unstructured":"Miner, J. & Hoffhines, A. The discovery of aspirin\u2019s antithrombotic effects. Tex. Heart Inst. J. 34, 179\u2013186 (2007).","journal-title":"Tex. Heart Inst. J."},{"key":"77034_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/2040620711413165","volume":"2","author":"W Rehman","year":"2011","unstructured":"Rehman, W., Arfons, L. M. & Lazarus, H. M. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther. Adv. Hematol. 2, 291\u2013308 (2011).","journal-title":"Ther. Adv. Hematol."},{"key":"77034_CR7","doi-asserted-by":"crossref","unstructured":"Mateo, J., Ong, M., Yap, T. A. & de Bono, J. S. Opportunities and pitfalls of targeted therapeutic combinations in solid tumors. Am. Soc. Clin. Oncol. Educ. Book 32, 670\u2013674 (2012).","DOI":"10.14694\/EdBook_AM.2012.32.191"},{"key":"77034_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","volume":"186","author":"HK Patel","year":"2018","unstructured":"Patel, H. K. & Bihani, T. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol. Therapeutics 186, 1\u201324 (2018).","journal-title":"Pharmacol. Therapeutics"},{"key":"77034_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1634\/theoncologist.7-6-477","volume":"7","author":"PF Bross","year":"2002","unstructured":"Bross, P. F., Cohen, M. H., Williams, G. A. & Pazdur, R. FDA drug approval summaries: fulvestrant. Oncologist 7, 477\u2013480 (2002).","journal-title":"Oncologist"},{"key":"77034_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/cancers16030619","volume":"16","author":"N Neupane","year":"2024","unstructured":"Neupane, N. et al. Oral SERD, a novel endocrine therapy for estrogen receptor-positive breast cancer. Cancers 16, 619 (2024).","journal-title":"Cancers"},{"key":"77034_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10549-022-06797-9","volume":"197","author":"A Bardia","year":"2023","unstructured":"Bardia, A. et al. The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR+\/HER2\u2212) advanced\/metastatic breast cancer. Breast Cancer Res Treat. 197, 319\u2013331 (2023).","journal-title":"Breast Cancer Res Treat."},{"key":"77034_CR12","unstructured":"US National Library of Medicine. ClinicalTrials.gov. A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy (HydranGea). https:\/\/clinicaltrials.gov\/study\/NCT02569801 (accessed 30 June 2026) (2021)."},{"key":"77034_CR13","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1158\/1078-0432.CCR-23-0011","volume":"29","author":"S Chandarlapaty","year":"2023","unstructured":"Chandarlapaty, S. et al. An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor\u2013positive breast cancer. Clin. Cancer Res. 29, 2781\u20132790 (2023).","journal-title":"Clin. Cancer Res."},{"key":"77034_CR14","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1200\/JCO.22.02746","volume":"41","author":"SM Tolaney","year":"2023","unstructured":"Tolaney, S. M. et al. AMEERA-3: randomized phase II study of amcenestrant (oral selective estrogen receptor degrader) versus standard endocrine monotherapy in estrogen receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative advanced breast cancer. JCO 41, 4014\u20134024 (2023).","journal-title":"JCO"},{"key":"77034_CR15","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1158\/1078-0432.CCR-19-3387","volume":"26","author":"JFR Robertson","year":"2020","unstructured":"Robertson, J. F. R. et al. A randomized, open-label, presurgical, window-of-opportunity study comparing the pharmacodynamic effects of the novel oral SERD AZD9496 with fulvestrant in patients with newly diagnosed ER+ HER2\u2212 primary breast cancer. Clin. Cancer Res. 26, 4242\u20134249 (2020).","journal-title":"Clin. Cancer Res."},{"key":"77034_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.cell.2019.06.026","volume":"178","author":"J Guan","year":"2019","unstructured":"Guan, J. et al. Therapeutic ligands antagonize estrogen receptor function by impairing its mobility. Cell 178, 949\u2013963.e18 (2019).","journal-title":"Cell"},{"key":"77034_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/me.2009-0252","volume":"24","author":"TH Charn","year":"2010","unstructured":"Charn, T. H. et al. Genome-wide dynamics of chromatin binding of estrogen receptors \u03b1 and \u03b2: mutual restriction and competitive site selection. Mol. Endocrinol. 24, 47\u201359 (2010).","journal-title":"Mol. Endocrinol."},{"key":"77034_CR18","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/jcb.24584","volume":"114","author":"NR Candelaria","year":"2013","unstructured":"Candelaria, N. R., Liu, K. & Lin, C.-Y. Estrogen receptor alpha: molecular mechanisms and emerging insights. J. Cell. Biochem. 114, 2203\u20132208 (2013).","journal-title":"J. Cell. Biochem."},{"key":"77034_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2005.12.016","volume":"21","author":"ASL Cheng","year":"2006","unstructured":"Cheng, A. S. L. et al. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-\u03b1 responsive promoters. Mol. Cell 21, 393\u2013404 (2006).","journal-title":"Mol. Cell"},{"key":"77034_CR20","doi-asserted-by":"publisher","first-page":"29298","DOI":"10.1074\/jbc.M109.037010","volume":"284","author":"KW Jeong","year":"2009","unstructured":"Jeong, K. W., Lee, Y.-H. & Stallcup, M. R. Recruitment of the SWI\/SNF chromatin remodeling complex to steroid hormone-regulated promoters by nuclear receptor coactivator flightless-I. J. Biol. Chem. 284, 29298\u201329309 (2009).","journal-title":"J. Biol. Chem."},{"key":"77034_CR21","doi-asserted-by":"publisher","first-page":"11540","DOI":"10.1073\/pnas.93.21.11540","volume":"93","author":"B Hanstein","year":"1996","unstructured":"Hanstein, B. et al. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93, 11540\u201311545 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77034_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF02967999","volume":"11","author":"T Toyama","year":"2004","unstructured":"Toyama, T. & Iwase, H. p33ING1b and estrogen receptor (ER) alpha. Breast Cancer 11, 33\u201337 (2004).","journal-title":"Breast Cancer"},{"key":"77034_CR23","doi-asserted-by":"publisher","first-page":"15395","DOI":"10.1021\/acsnano.4c14943","volume":"19","author":"G Nishide","year":"2025","unstructured":"Nishide, G. et al. Zooming into gene activation: estrogen receptor \u03b1 dimerization and DNA binding visualized by high-speed atomic force microscopy. ACS Nano 19, 15395\u201315410 (2025).","journal-title":"ACS Nano"},{"key":"77034_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15896","volume":"8","author":"V Paakinaho","year":"2017","unstructured":"Paakinaho, V. et al. Single-molecule analysis of steroid receptor and cofactor action in living cells. Nat. Commun. 8, 15896 (2017).","journal-title":"Nat. Commun."},{"key":"77034_CR25","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1242\/jcs.03161","volume":"119","author":"ZD Sharp","year":"2006","unstructured":"Sharp, Z. D. et al. Estrogen-receptor-\u03b1 exchange and chromatin dynamics are ligand- and domain-dependent. J. Cell Sci. 119, 4101\u20134116 (2006).","journal-title":"J. Cell Sci."},{"key":"77034_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1677\/jme.1.01541","volume":"33","author":"CM Klinge","year":"2004","unstructured":"Klinge, C. M., Jernigan, S. C., Mattingly, K. A., Risinger, K. E. & Zhang, J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors \u03b1 and \u03b2 by coactivators and corepressors. J. Mol. Endocrinol. 33, 387\u2013410 (2004).","journal-title":"J. Mol. Endocrinol."},{"key":"77034_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41388-018-0468-9","volume":"38","author":"T Traboulsi","year":"2019","unstructured":"Traboulsi, T., El Ezzy, M., Dumeaux, V., Audemard, E. & Mader, S. Role of SUMOylation in differential ER\u03b1 transcriptional repression by tamoxifen and fulvestrant in breast cancer cells. Oncogene 38, 1019\u20131037 (2019).","journal-title":"Oncogene"},{"key":"77034_CR28","doi-asserted-by":"crossref","unstructured":"Agbo, L., Blanchet, S. A., Kougnassoukou Tchara, P.-E., Fradet-Turcotte, A. & Lambert, J.-P. Comprehensive interactome mapping of nuclear receptors using proximity biotinylation. In Proteomics in Systems Biology: Methods and Protocols (ed. Geddes-McAlister, J.) 223\u2013240 (Springer US, 2022).","DOI":"10.1007\/978-1-0716-2124-0_15"},{"key":"77034_CR29","doi-asserted-by":"publisher","first-page":"100702","DOI":"10.1016\/j.mcpro.2023.100702","volume":"23","author":"C Rega","year":"2024","unstructured":"Rega, C. et al. Exploring the spatial landscape of the Estrogen Receptor proximal proteome with antibody-based proximity labeling. Mol. Cell. Proteom. 23, 100702 (2024).","journal-title":"Mol. Cell. Proteom."},{"key":"77034_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.aay4106","volume":"367","author":"JB Geri","year":"2020","unstructured":"Geri, J. B. et al. Microenvironment mapping via Dexter energy transfer on immune cells. Science 367, 1091\u20131097 (2020).","journal-title":"Science"},{"key":"77034_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208077119","volume":"119","author":"AD Trowbridge","year":"2022","unstructured":"Trowbridge, A. D. et al. Small molecule photocatalysis enables drug target identification via energy transfer. Proc. Natl. Acad. Sci. USA 119, e2208077119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77034_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41586-023-05914-y","volume":"616","author":"CP Seath","year":"2023","unstructured":"Seath, C. P. et al. Tracking chromatin state changes using nanoscale photo-proximity labelling. Nature 616, 574\u2013580 (2023).","journal-title":"Nature"},{"key":"77034_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203027119","volume":"119","author":"JV Oakley","year":"2022","unstructured":"Oakley, J. V. et al. Radius measurement via super-resolution microscopy enables the development of a variable radii proximity labeling platform. Proc. Natl. Acad. Sci. USA 119, e2203027119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77034_CR34","unstructured":"DepMap: The Cancer Dependency Map Project at Broad Institute. https:\/\/depmap.org\/portal\/ (2026)."},{"key":"77034_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","volume":"25","author":"R Arafeh","year":"2025","unstructured":"Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C. & Vazquez, F. The present and future of the Cancer Dependency Map. Nat. Rev. Cancer 25, 59\u201373 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"77034_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2414377121","volume":"121","author":"A Fu","year":"2024","unstructured":"Fu, A. et al. Nuclear p62 condensates stabilize the promyelocytic leukemia nuclear bodies by sequestering their ubiquitin ligase RNF4. Proc. Natl. Acad. Sci. USA 121, e2414377121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77034_CR37","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1074\/jbc.M109.039925","volume":"285","author":"S Pankiv","year":"2010","unstructured":"Pankiv, S. et al. Nucleocytoplasmic shuttling of p62\/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J. Biol. Chem. 285, 5941\u20135953 (2010).","journal-title":"J. Biol. Chem."},{"key":"77034_CR38","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1093\/nar\/gkaa828","volume":"48","author":"A Corpet","year":"2020","unstructured":"Corpet, A. et al. PML nuclear bodies and chromatin dynamics: catch me if you can!. Nucleic Acids Res. 48, 11890\u201311912 (2020).","journal-title":"Nucleic Acids Res."},{"key":"77034_CR39","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/sj.cdd.4401313","volume":"10","author":"TG Hofmann","year":"2003","unstructured":"Hofmann, T. G. & Will, H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10, 1290\u20131299 (2003).","journal-title":"Cell Death Differ."},{"key":"77034_CR40","doi-asserted-by":"publisher","first-page":"a000661","DOI":"10.1101\/cshperspect.a000661","volume":"2","author":"V Lallemand-Breitenbach","year":"2010","unstructured":"Lallemand-Breitenbach, V. & de Th\u00e9, H. PML nuclear bodies. Cold Spring Harb. Perspect. Biol. 2, a000661 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"77034_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"77034_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1101\/gad.1975111","volume":"25","author":"M Vernier","year":"2011","unstructured":"Vernier, M. et al. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev. 25, 41\u201350 (2011).","journal-title":"Genes Dev."},{"key":"77034_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.molcel.2019.03.020","volume":"74","author":"BR Topacio","year":"2019","unstructured":"Topacio, B. R. et al. Cyclin D-Cdk4,6 drives cell-cycle progression via the retinoblastoma protein\u2019s C-terminal helix. Mol. Cell 74, 758\u2013770.e4 (2019).","journal-title":"Mol. Cell"},{"key":"77034_CR44","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1128\/MCB.00290-12","volume":"32","author":"K Hilmi","year":"2012","unstructured":"Hilmi, K. et al. Role of SUMOylation in full antiestrogenicity. Mol. Cell Biol. 32, 3823\u20133837 (2012).","journal-title":"Mol. Cell Biol."},{"key":"77034_CR45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0092-8674(82)90218-5","volume":"28","author":"KB Horwitz","year":"1982","unstructured":"Horwitz, K. B., Mockus, M. B. & Lessey, B. A. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28, 633\u2013642 (1982).","journal-title":"Cell"},{"key":"77034_CR46","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.31557\/APJCP.2019.20.12.3763","volume":"20","author":"OS El-Masry","year":"2019","unstructured":"El-Masry, O. S., Brown, B. L. & Dobson, P. R. M. AMPK activation of apoptotic markers in human breast cancer cell lines with different p53 backgrounds: MCF-7, MDA-MB-231 and T47D Cells. Asian Pac. J. Cancer Prev. 20, 3763\u20133770 (2019).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"77034_CR47","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/812540","volume":"2011","author":"R Kumar","year":"2011","unstructured":"Kumar, R. et al. The dynamic structure of the estrogen receptor. J. Amino Acids 2011, 812540 (2011).","journal-title":"J. Amino Acids"},{"key":"77034_CR48","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nprot.2018.015","volume":"13","author":"PJ Skene","year":"2018","unstructured":"Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006\u20131019 (2018).","journal-title":"Nat. Protoc."},{"key":"77034_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1677\/jme.0.0270093","volume":"27","author":"L Bjornstrom","year":"2001","unstructured":"Bjornstrom, L., Kilic, E., Norman, M., Parker, M. G. & Sjoberg, M. Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J. Mol. Endocrinol. 27, 93\u2013106 (2001).","journal-title":"J. Mol. Endocrinol."},{"key":"77034_CR50","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ccell.2020.06.007","volume":"38","author":"R Siersb\u00e6k","year":"2020","unstructured":"Siersb\u00e6k, R. et al. IL6\/STAT3 signaling hijacks ER enhancers to drive breast cancer metastasis. Cancer Cell 38, 412\u2013423.e9 (2020).","journal-title":"Cancer Cell"},{"key":"77034_CR51","doi-asserted-by":"publisher","first-page":"e36499","DOI":"10.1016\/j.heliyon.2024.e36499","volume":"10","author":"C Fracassi","year":"2024","unstructured":"Fracassi, C., Simoni, M., Ugg\u00e8, M., Morelli, M. J. & Bernardi, R. PML is a constitutive component of chromatin domains enriched in repetitive elements and duplicated gene clusters in cancer cells. Heliyon 10, e36499 (2024).","journal-title":"Heliyon"},{"key":"77034_CR52","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1126\/science.1243490","volume":"342","author":"AB Stergachis","year":"2013","unstructured":"Stergachis, A. B. et al. Exonic transcription factor binding directs codon choice and impacts protein evolution. Science 342, 1367\u20131372 (2013).","journal-title":"Science"},{"key":"77034_CR53","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.cell.2019.11.002","volume":"179","author":"A Fiszbein","year":"2019","unstructured":"Fiszbein, A., Krick, K. S., Begg, B. E. & Burge, C. B. Exon-mediated activation of transcription starts. Cell 179, 1551\u20131565.e17 (2019).","journal-title":"Cell"},{"key":"77034_CR54","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1021\/acschembio.4c00606","volume":"19","author":"L Wang","year":"2024","unstructured":"Wang, L. & Han, T. Pharmacologic induction of ER\u03b1 SUMOylation disrupts its chromatin binding. ACS Chem. Biol. 19, 2383\u20132392 (2024).","journal-title":"ACS Chem. Biol."},{"key":"77034_CR55","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molcel.2023.06.028","volume":"83","author":"JM Tsai","year":"2023","unstructured":"Tsai, J. M. et al. UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability. Mol. Cell 83, 2753\u20132767.e10 (2023).","journal-title":"Mol. Cell"},{"key":"77034_CR56","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1200\/JCO-24-02086","volume":"43","author":"K Kalinsky","year":"2025","unstructured":"Kalinsky, K. et al. Abemaciclib plus fulvestrant in advanced breast cancer after progression on CDK4\/6 inhibition: results from the phase III postMONARCH trial. JCO 43, 1101\u20131112 (2025).","journal-title":"JCO"},{"key":"77034_CR57","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41557-020-0474-8","volume":"12","author":"AJ Burton","year":"2020","unstructured":"Burton, A. J. et al. In situ chromatin interactomics using a chemical bait and trap approach. Nat. Chem. 12, 520\u2013527 (2020).","journal-title":"Nat. Chem."},{"key":"77034_CR58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68\u201385 (2019).","journal-title":"Nat. Protoc."},{"key":"77034_CR59","unstructured":"The Galaxy Community. The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update. Nucleic Acids Res. 52, W83\u2013W94 (2024)."},{"key":"77034_CR60","unstructured":"Krueger, F. Trim Galore. Github https:\/\/github.com\/felixkrueger\/trimgalore (2026)."},{"key":"77034_CR61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"77034_CR62","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/bioinformatics\/btr174","volume":"27","author":"DW Barnett","year":"2011","unstructured":"Barnett, D. W., Garrison, E. K., Quinlan, A. R., Str\u00f6mberg, M. P. & Marth, G. T. BamTools: a C++ API and toolkit for analyzing and managing BAM files. Bioinformatics 27, 1691\u20131692 (2011).","journal-title":"Bioinformatics"},{"key":"77034_CR63","unstructured":"Broad Institute. Picard Tools https:\/\/broadinstitute.github.io\/picard\/ (2026)."},{"key":"77034_CR64","doi-asserted-by":"publisher","DOI":"10.1101\/496521","author":"JM Gaspar","year":"2018","unstructured":"Gaspar, J. M. Improved peak-calling with MACS2. Prepr. BioRxiv https:\/\/doi.org\/10.1101\/496521 (2018).","journal-title":"Prepr. BioRxiv"},{"key":"77034_CR65","doi-asserted-by":"publisher","first-page":"W39","DOI":"10.1093\/nar\/gkv416","volume":"43","author":"TL Bailey","year":"2015","unstructured":"Bailey, T. L., Johnson, J., Grant, C. E. & Noble, W. S. The MEME Suite. Nucleic Acids Res. 43, W39\u2013W49 (2015).","journal-title":"Nucleic Acids Res."},{"key":"77034_CR66","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"77034_CR67","unstructured":"Homer Software and Data Download. http:\/\/homer.ucsd.edu\/homer\/ (2026)."},{"key":"77034_CR68","unstructured":"Stark, R. & Brown, G. D. DiffBind: Differential binding analysis of ChIP-Seq peak data. Bioconductor https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/DiffBind.html (2012)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77034-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:02:45Z","timestamp":1790852565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77034-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77034"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77034-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.W.C.M. declares an ownership interest in the company Dexterity Pharma LLC, which has commercialized materials used in this work. R.O.G., K.D., Y.A., J.L.S., A.M.K., and J.W.T. are employees and shareholders of Bristol Myers Squibb. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10379"}}